Fairvalue-Calculator Fairvalue-Calculator
EN DE

Zura Bio Limited (ZURA) Fair Value & Analysis

Healthcare · US · Market cap $404M

Price$4.26
Fair Value$1.05
Upside-75.4%
Quality91/100
Evidence: Low Range $0.6900 – $1.32

Fair value as of: Jun 25, 2026

Analysis

Zura Bio Limited (ZURA) currently trades at $4.26, while our model-based Fair Value estimate is $1.05 — implying the stock looks roughly 75.4% overvalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development. It also develops Torudokimab (ZB-880), a fully human immunoglobulin G4 monoclonal antibody targeting interleukin-33 that has completed Phase 1 clinical studies; and Crebankitug (ZB-168), a fully human immunoglobulin G1 monoclonal antibody targeting interleukin-7 receptor alpha that has completed Phase 1 clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) -28% Alnylam Pharmaceuticals, Inc (ALNY) -63%

Frequently asked questions

Is Zura Bio Limited (ZURA) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $1.05 versus a price of $4.26 — about −75% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ZURA?
Our 21-model fair value for Zura Bio Limited is $1.05 (as of Jun 25, 2026), built from audited fundamentals. The current price is $4.26.
What is the quality score of ZURA?
Zura Bio Limited has a Quality Score of 91/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.